MedPath

ZEMAIRA

ZEMAIRA

Approved
DIN Number

02494779

Drug Class

Human

Market Date

N/A

Company
HC

csl behring canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02494779
AIG Number0120888008
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02AB02 ALFA1 ANTITRYPSIN
Product Specifications
Dosage FormPowder For Solution ,  Kit
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ALPHA1-PROTEINASE INHIBITOR (HUMAN)Active
Strength: 5000 MG / VIAL
Monograph: ALPHA1-PROTEINASE INHIBITOR (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.